INDBInternet News Database 2.5 Updated 1 min ago · 288 sources Show or hide images Light or dark

GLP-1 Therapies Not Linked to Fracture Risk in Three Studies

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage

Summary

The studies have found no clear increase in fractures, whereas some analyses have suggested lower risk among postmenopausal women taking semaglutide or tirzepatide.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    GLP-1 Therapies Not Linked to Fracture Risk in Three Studies

    The studies have found no clear increase in fractures, whereas some analyses have suggested lower risk among postmenopausal women taking semaglutide or tirzepatide.

Comments

Comments need JavaScript.